Gain Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.03

+0.05 (+2.53%)

As of Jun 30, 10:37 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 91%

Hold 1 9%

Sell 0 0%

Price Target

Analyst Price Target +1,380.3% upside

Low Target $22.12

Average Target $30.05

High Target $38.96

Current Price $2.03

Current
$2.03

Target
$30.05

$22.12 $30.05 avg $38.96

Scenario Analysis

Bear Case

$22.12

989.7%

Low target

Base Case

$30.05

+1,380.3%

Avg target

Bull Case

$38.96

+1,819.2%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$4.34

-53.2% from high

52-Week Low

$1.41

+44.0% from low

Target vs 52W High

$30.05

+592.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%